Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

NCT06125262 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Immunotherapy
Chemotherapy

Sponsor

Guangdong Provincial People's Hospital